Citizen in a RepublicNH Bill Briefing
← All bills

HB 1292 · 2026 · House · Judiciary Committee

Right to try expansion for stem cells

AI-generated

expanding the right to try act to include certain qualifying severe illness and permitting certain regenerative stem cell therapies under the act.

Extends the right to try act to patients with a qualifying severe illness, permits access to certain unapproved treatments, regulates regenerative stem cell therapies including consent and disclosure requirements, and authorizes injunctive relief for violations.AI-generated

Status

Referred to interim study (House) · March 5, 2026
  1. ✓Introduced
  2. ✕House
  3. Senate
  4. Governor
  5. Law

Analysis

This bill: I. Extends the right to try act to include patients with "qualifying severe illness" and defines related terms. II. Removes the definition of "investigational drug, biologic, or device." III. Permits access to unapproved treatments under specified conditions and adds a new section regulating regenerative stem cell therapies, including consent, accreditation, advertising, and disclosure requirements. IV. Authorizes injunctive relief for violations and prohibits the use of stem cells derived from a fetus or embryo after an abortion.

From the bill's official ANALYSIS section.

In the bill's words

Quoted verbatim from the bill as introduced. Passages chosen from the operative text.Computed by this site

“"Eligible facility" means a licensed New Hampshire institution that is operating under a Federalwide Assurance ("FWA") for the Protection of Human Subjects under 42 U.S.C. section 289(a) and 45 C.F.R. part 46.”
RSA 126-Z:1
“A manufacturer [of an investigational drug, biologic, or device] may make [available an investigational] a drug, biologic, or device [to eligible patients pursuant to this chapter.”
RSA 126-Z:2
“Notwithstanding any provision of law to the contrary, the board of medicine shall not revoke, fail to renew, or take any other action against a physician's license issued pursuant to RSA 329 based primarily on a physician's recommendation to [an eligible] a patient regarding or prescription for or treatment with [an investigational] a drug, biologic, or device pursuant to this chapter.”
RSA 126-Z:3
“Nothing in this chapter shall be construed to create a private cause of action against any person or entity except as specified in paragraph II.”
RSA 126-Z:4

Official record

Bill page — docket & status

gc.nh.gov · the authoritative source

Sponsors

Rep. Erica LayonRPrimeChair· Executive Departments and Administration
  • Rep. Dan McGuireRVice Chair· Finance
  • Rep. Sayra DeVitoRClerk· Fish and Game and Marine Resources
  • Sen. Keith MurphyRDeputy President Pro Tempore
  • Sen. Victoria SullivanRVice Chair· Education

Also: Rep. Daniel Popovici-MullerR, Rep. Matt Sabourin dit ChoinièreR, Rep. Mary MurphyR, Rep. Yury PolozovR, Rep. Cyril AuresR

Public testimony

154 signed in online · 37 wrote testimony

95% support5% oppose0% neutral

In their wordsVerbatim, exactly as submitted

“I would ask that you please support this bill. Using aborted baby parts is just horrible, killing babies is horrible! Thank you,”
— Paula Jordan, WENTWORTHsupports
“I oppose the use of aborted baby parts for any reason whatsoever. Our own stem cells can be harvested to successfully treat our health conditions. I respectfully ask that you support HB 1292.”
— Patricia Dickinson, Claremontsupports
“My wife and I wholeheartedly support this bill. It will help ensure that abortion is not incentivized through harvesting aborted babies' body parts. May we keep sacred those who would have grown up in our world.…”
— Mark French, Derrysupports
“NHMS is speaking in opposition to HB1292 •We have concerns about administering drugs that have not been through a thorough testing and approval process. This bill removes requirements that a drug has completed phase one of a clinical trial.…”
— Cathy Stratton, Concord · New Hampshire Medical Societyopposes
“I really wish people like Erica would stop trying to criminalized healthcare, this is a step backwards, not a step forward for New Hampshire. Everything Florida does should be a warning to us. We shouldn’t be trying to emulate them.…”
— Michelle Moge, Derryopposes

Verbatim excerpts of submitted testimony, quoted from the testimony tool.

Read the testimony · as of Aug 12, 2026

Votes

yeanay
Starting text: Bill as introduced
  • Feb 13, 2026HouseCommittee report· consent calendar: Refer for Interim Study17–1
    Overall
    94% yea
  • Mar 5, 2026HouseVoice voteRefer for Interim Studyadopted

Hearings and debates

  • Feb 11, 2026Public hearingHouse Judiciary3:42:19–3:47:054m 46slocated in the stream transcriptPublic Hearing
  • Feb 13, 2026Public hearingHouse Judiciary34:55–36:381m 43slocated in the stream transcriptCommittee Report: Refer for Interim Study; Executive Session
  • Mar 5, 2026Floor debateHouse floorWatchnot located in the transcript — opens the full streamRefer for Interim Study — adopted, voice vote

Timestamps locate where this bill is taken up in the chamber's YouTube stream.

Legislative history

  1. Jan 7, 2026HouseIntroduced 01/07/2026 and referred to Judiciary HJ 1 P. 14
  2. Feb 11, 2026HousePublic Hearing: 02/11/2026 01:00 pm GP 230
  3. Feb 13, 2026HouseExecutive Session: 02/13/2026 10:00 am GP 158
  4. Feb 13, 2026HouseCommittee Report: Refer for Interim Study 02/13/2026 (Vote 17-1; CC) HC 9 P. 18
  5. Mar 5, 2026HouseRefer for Interim Study: MA VV 03/05/2026 HJ 6 P. 24

Coverage

No reporting linked yet.

Documents (PDF)

Bill text & amendments link direct to gc.nh.gov; committee reports stream from the state record.